Cosmos Health Inc. (COSM)
NASDAQ: COSM
· Real-Time Price · USD
0.44
-0.00 (-0.63%)
At close: May 23, 2025, 3:50 PM
0.44
-0.97%
After-hours: May 23, 2025, 07:50 PM EDT
Cosmos Health Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2023 |
---|---|---|
Nutraceuticals and Pharmaceuticals Revenue | n/a | n/a |
Nutraceuticals and Pharmaceuticals Revenue Growth | n/a | n/a |
Other Revenue | n/a | n/a |
Other Revenue Growth | n/a | n/a |
Wholesale Revenue | n/a | n/a |
Wholesale Revenue Growth | n/a | n/a |
Revenue by Geography
Period Ending | Dec 31, 2024 | Dec 31, 2023 |
---|---|---|
Other Revenue | n/a | n/a |
Other Revenue Growth | n/a | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 1.51M | 8.83M | 3.14M | 2.96M | 2.85M | 14.68M | 3.98M | 3.4M | 3.51M | 7.88M | 2.02M | 1.81M | 1.54M | 3.33M | 3.15M | 3.3M | 2.63M | 1.6M | 1.23M | 1.25M | 867.6K | 1.05M | 823.48K | 903.97K | 743.53K | 1.33M | 743.36K | 772.78K | 751.75K | 2.44M | 752.2K | 1.27M | 393.49K | 327.81K | 173.5K | 167.73K | 125.06K | 223.79K | 68.16K | 109.8K | 84.28K |
Selling, General, and Administrative Revenue Growth | -82.94% | +181.07% | +6.30% | +3.73% | -80.59% | +268.55% | +17.30% | -3.13% | -55.50% | +290.97% | +11.25% | +17.85% | -53.87% | +5.71% | -4.63% | +25.88% | +64.05% | +30.15% | -1.72% | +44.19% | -17.57% | +27.81% | -8.90% | +21.58% | -43.89% | +78.28% | -3.81% | +2.80% | -69.14% | +223.89% | -40.81% | +222.97% | +20.04% | +88.94% | +3.44% | +34.12% | -44.12% | +228.36% | -37.93% | +30.28% | n/a |
Research and Development Revenue | 15.63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales and Marketing Revenue | 28.16K | 28.68K | 41.85K | 110.81K | 173.63K | 261.88K | 157.44K | 318.06K | 467.26K | 133.69K | 103.98K | 245.44K | 146.95K | 146.1K | 41.72K | 139.63K | 405.09K | 117.24K | 211.87K | 380.33K | 53.73K | n/a | 15.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.1K |
Sales and Marketing Revenue Growth | -1.82% | -31.47% | -62.24% | -36.18% | -33.70% | +66.34% | -50.50% | -31.93% | +249.52% | +28.57% | -57.64% | +67.03% | +0.58% | +250.25% | -70.13% | -65.53% | +245.52% | -44.67% | -44.29% | +607.86% | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a |